These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 33552069)

  • 61. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
    Wang J; Jiang M; Chen X; Montaner LJ
    J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hyperinflammation and Immune Response Generation in COVID-19.
    Mishra KP; Singh AK; Singh SB
    Neuroimmunomodulation; 2020; 27(2):80-86. PubMed ID: 33341814
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
    Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
    Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nexus between COVID-19 and periodontal disease.
    Sukumar K; Tadepalli A
    J Int Med Res; 2021 Mar; 49(3):3000605211002695. PubMed ID: 33745336
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection.
    Battina HL; Alentado VJ; Srour EF; Moliterno AR; Kacena MA
    Exp Hematol; 2021 Dec; 104():32-39. PubMed ID: 34563606
    [No Abstract]   [Full Text] [Related]  

  • 67. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
    Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
    Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.
    Song NJ; Allen C; Vilgelm AE; Riesenberg BP; Weller KP; Reynolds K; Chakravarthy KB; Kumar A; Khatiwada A; Sun Z; Ma A; Chang Y; Yusuf M; Li A; Zeng C; Evans JP; Bucci D; Gunasena M; Xu M; Liyanage NPM; Bolyard C; Velegraki M; Liu SL; Ma Q; Devenport M; Liu Y; Zheng P; Malvestutto CD; Chung D; Li Z
    J Hematol Oncol; 2022 Jan; 15(1):5. PubMed ID: 35012610
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
    Fong SW; Yeo NK; Chan YH; Goh YS; Amrun SN; Ang N; Rajapakse MP; Lum J; Foo S; Lee CY; Carissimo G; Chee RS; Torres-Ruesta A; Tay MZ; Chang ZW; Poh CM; Young BE; Tambyah PA; Kalimuddin S; Leo YS; Lye DC; Lee B; Biswas S; Howland SW; Renia L; Ng LFP
    J Clin Immunol; 2022 Feb; 42(2):214-229. PubMed ID: 34716845
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.
    Alshammary AF; Al-Sulaiman AM
    Virulence; 2021 Dec; 12(1):1771-1794. PubMed ID: 34251989
    [TBL] [Abstract][Full Text] [Related]  

  • 73. GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro.
    Hong KS; Ahn JH; Jang JG; Lee JH; Kim HN; Kim D; Lee W
    Signal Transduct Target Ther; 2020 Nov; 5(1):267. PubMed ID: 33203839
    [No Abstract]   [Full Text] [Related]  

  • 74. A Cytokine/Bradykinin Storm Comparison: What Is the Relationship Between Hypertension and COVID-19?
    Wilczynski SA; Wenceslau CF; McCarthy CG; Webb RC
    Am J Hypertens; 2021 Apr; 34(4):304-306. PubMed ID: 33877321
    [No Abstract]   [Full Text] [Related]  

  • 75. Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases.
    Tang XD; Ji TT; Dong JR; Feng H; Chen FQ; Chen X; Zhao HY; Chen DK; Ma WT
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884813
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    Mardi A; Meidaninikjeh S; Nikfarjam S; Majidi Zolbanin N; Jafari R
    Viral Immunol; 2021 Dec; 34(10):679-688. PubMed ID: 34882013
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    Cell; 2021 Jan; 184(1):149-168.e17. PubMed ID: 33278357
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage.
    Bass A; Liu Y; Dakshanamurthy S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960687
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2.
    Cheon SY; Koo BN
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.